孕早期胎盘超声研究:OxNNet自动胎盘体积预测胎儿生长受限
本研究基于FirstPLUS队列3500例单胎妊娠,于孕11+2至14+1周行三维胎盘超声,用OxNNet自动分割计算胎盘体积(FTPV)。低FTPV Z评分是FGR独立危险因素(OR 1.736),将FTPV加入母体因素与生物标志物模型使全部FGR预测AUC从0.78升至0.79(P=0.005)。
要点
- 孕早期FTPV Z评分每降低1单位,FGR风险增加(OR 1.736,95%CI 1.499-2.015)。
- FTPV加入基础模型使全部FGR预测AUC由0.78升至0.79(P=0.005),血压正常亚组由0.77升至0.78(P=0.01)。
- 早产FGR预测AUC加与不加FTPV均为0.85(P=0.93),差异不显著可能受限于样本量。
核心结论
- FTPV Z评分是FGR的预测因子,将其整合入预测模型可显著提升对所有FGR及血压正常亚组FGR的判别能力。
研究设计与样本
- FirstPLUS为前瞻性纵向观察队列研究,在英国伦敦King's College Hospital于2022年3月至11月招募,最终纳入3500例妊娠。
- 受试者在孕11+2至14+1周接受常规超声及三维胎盘超声,使用OxNNet工具包自动分割胎盘并计算体积。
- 采用多变量逻辑回归构建FGR预测模型,纳入母体因素、孕早期生物标志物(PAPP-A、平均动脉压、子宫动脉搏动指数)及FTPV。
主要发现
- 队列中250例(7.1%)发生FGR。
- FTPV Z评分每降低1单位,FGR的OR为1.736(95%CI 1.499-2.015)。
- 在母体因素与生物标志物模型基础上加入FTPV,全部FGR预测AUC从0.78(95%CI 0.75-0.81)升至0.79(95%CI 0.76-0.82),P=0.005。
- 血压正常亚组中,加入FTPV使FGR预测AUC从0.77(95%CI 0.74-0.80)升至0.78(95%CI 0.75-0.81),P=0.01。
- 早产FGR预测中,含FTPV模型AUC为0.85(95%CI 0.78-0.92),不含FTPV为0.85(95%CI 0.79-0.92),P=0.93。
关键数值与推荐
- FGR总体发生率为7.1%(250/3500)。
- FTPV Z评分每降低1单位对应FGR的OR=1.736(95%CI 1.499-2.015)。
- 全部FGR预测模型加入FTPV前后AUC分别为0.79(95%CI 0.76-0.82)与0.78(95%CI 0.75-0.81),P=0.005。
- 血压正常FGR预测模型加入FTPV前后AUC分别为0.78(95%CI 0.75-0.81)与0.77(95%CI 0.74-0.80),P=0.01。
- 早产FGR预测模型加入FTPV前后AUC均为0.85(95%CI 0.78-0.92 vs 0.79-0.92),P=0.93。
临床怎么用
- 孕早期三维胎盘超声联合OxNNet自动测量FTPV,可辅助识别FGR高风险孕妇。
- FTPV Z评分可作为现有母体因素与生物标志物模型的补充指标,提升FGR预测判别力。
- 对血压正常孕妇,加入FTPV同样可改善FGR预测,提示该指标在低危人群中的潜在价值。
局限性
- 早产FGR亚组分析中FTPV未显示显著增益(P=0.93),作者认为可能因样本量不足导致检验效能有限。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To develop predictive models for fetal growth restriction (FGR) with and without the inclusion of OxNNet-derived first-trimester placental volume (FTPV), thereby evaluating the contribution of FTPV to these models and the extent to which FTPV percentile is associated with subsequent FGR. METHODS: This study utilized data from the First-trimester Placental Ultrasound (FirstPLUS) study, a longitudinal observational cohort study conducted at King's College Hospital NHS Foundation Trust, London, UK, between March and November 2022. Participants underwent routine ultrasound assessment between 11 + 2 and 14 + 1 weeks' gestation, in addition to three-dimensional placental sonography. The OxNNet toolkit was used for automated placental segmentation and volume calculation. Multivariable logistic regression models were developed to predict FGR, incorporating maternal factors, first-trimester biomarkers (serum pregnancy-associated plasma protein-A, mean arterial blood pressure and uterine artery pulsatility index) and FTPV. RESULTS: The final cohort comprised 3500 pregnancies, of which 250 (7.1%) developed FGR. Low FTPV was found to be a risk factor for FGR, with an odds ratio of 1.736 (95% CI, 1.499-2.015) per unit decrease in FTPV Z-score. Incorporating FTPV into the predictive model based on maternal factors and biomarkers significantly increased the area under the receiver-operating-characteristics curve (AUC) for predicting all cases of FGR, from 0.78 (95% CI, 0.75-0.81) to 0.79 (95% CI, 0.76-0.82) (P = 0.005). Subgroup analysis of normotensive and hypertensive cases demonstrated a statistically significant effect size for the prediction of FGR by FTPV Z-score in both groups. The addition of FTPV to the model based on maternal factors and biomarkers for the prediction of normotensive FGR increased the AUC from 0.77 (95% CI, 0.74-0.80) to 0.78 (95% CI, 0.75-0.81) (P = 0.01). For preterm FGR, the AUC was 0.85 (95% CI, 0.78-0.92) with FTPV and 0.85 (95% CI, 0.79-0.92) without (P = 0.93); the absence of a significant difference may be due to a lack of power. CONCLUSIONS: FTPV Z-score is a predictor of FGR. Integrating FTPV into predictive models significantly enhanced the discriminative ability for all cases of FGR, as well as for the subgroup of normotensive FGR. © 2025 The Author(s). Ultrasound in Obstetrics & Gynecology published by John Wiley & Sons Ltd on behalf of International Society of Ultrasound in Obstetrics and Gynecology.
引用
- Mathewlynn S, Starck LN, Wright D, et al. First-trimester Placental Ultrasound (FirstPLUS) study: prediction of fetal growth restriction using OxNNet-derived first-trimester placental volume. Ultrasound Obstet Gynecol. 2025. PMID: 41351882. doi:10.1002/uog.70146
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。